Speaker
Asad Rashid, Heather Forster, Jonathon Romero
When and where
Starts: Tuesday, 22 April 2025 - 11:00
Ends: Tuesday, 22 April 2025 - 12:00
Location:
Xtalks, Toronto, Canada
Location details: Free Registration on Xtalks.com
Event description
As drug safety teams face increasing regulatory demands and growing data volumes, leveraging artificial intelligence (AI)-driven tools has become essential for improving accuracy, efficiency and cost-effectiveness in pharmacovigilance. In this webinar, the expert speakers will explore how AI can revolutionize drug safety case intake, transforming how case processing is managed.
Through a combination of real-world insights and expert perspectives, the expert speakers will cover:
- A step-by-step walkthrough of how a case is processed—from email intake to AI-driven analysis, human review and database integration
- A case study demonstrating the accuracy, speed and time-effectiveness of an AI tool compared to traditional methods
- An exclusive interview with a subject matter expert (SME) who actively uses the tool, sharing their experience and feedback on its impact in daily operations
By the end of this webinar, attendees will have a comprehensive understanding of how an AI-powered solution can enhance drug safety workflows, drive better decision-making and enable quicker processing. Whether you are a pharmacovigilance professional, regulatory expert or data scientist in life sciences, this webinar will provide valuable insights into the future of AI-driven drug safety management.
Register for this webinar today to discover how AI-driven tools can revolutionize drug safety case intake and streamline pharmacovigilance workflows.
Further details
IMPORTANT: In order to register to this free webinar you must register directly on Xtalks via the following URL: https://xtalks.com/webinars/how-ai-is-revolutionizing-drug-safety-case-intake-boosting-accuracy-efficiency-expertise/
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 94
- Comments 0